Safety
GLP-1s and Surgery: Why Anaesthetists Need to Know Before the Day
Medically reviewed by Dr. J. Adam, MD · Updated July 23, 2026 · Sources cited below
GLP-1 therapy slows gastric emptying, so food can remain in the stomach longer than standard preoperative fasting intervals assume. Under sedation or general anaesthesia, protective airway reflexes are suppressed and residual gastric contents can be aspirated. Tell your surgical, endoscopic, dental and anaesthetic teams when the procedure is booked, not on the day.
Key takeaways
- Delayed gastric emptying can leave stomach contents present despite correct fasting.
- The risk is pulmonary aspiration under sedation or general anaesthesia.
- Anaesthesia professional bodies have issued specific guidance for incretin therapies.
- Disclose at booking so the team can apply its protocol — not on the morning of the procedure.
- Whether to withhold a dose is a clinical decision for the procedural team, not a self-managed one.
| Mechanism of concern | Delayed gastric emptying |
|---|---|
| Risk | Pulmonary aspiration under sedation |
| Applies to | Surgery, endoscopy, dental and imaging procedures with sedation |
| Required action | Disclose at booking |
| Dose withholding | Clinical decision — not published here |
Why fasting rules stop working
Standard preoperative fasting intervals are built on an assumption: that the stomach empties at a reasonably predictable rate, so a defined number of hours without food leaves it empty. Incretin therapy slows that process, and the assumption stops holding.
The consequence is that a patient who has fasted exactly as instructed can still have residual gastric contents at induction. This is not a compliance failure and it is not detectable by asking the patient — it is a pharmacological effect that the fasting protocol was never designed to account for.
Anaesthesia societies responded with specific guidance after clinicians began encountering full stomachs in correctly fasted patients. That guidance is why disclosure matters more than any rule of thumb you could apply yourself.
Which procedures does this actually affect?
Anything involving sedation, which is a wider set than people assume. Surgery is obvious. Endoscopy and colonoscopy are high on the list because they involve both sedation and direct airway proximity. Some dental procedures use sedation. So do certain imaging studies.
The relevant question is not the size or seriousness of the procedure but whether protective airway reflexes will be suppressed. A short procedure under sedation carries the mechanism; a long procedure under local anaesthetic alone generally does not.
The gap in practice tends to open around dental and outpatient procedures. People reliably disclose their medication for a scheduled operation and frequently do not for a dental appointment.
View chart data as a table
| Group | Applies = 1 |
|---|---|
| Surgery under general anaesthesia | 1 |
| Endoscopy or colonoscopy with sedation | 1 |
| Dental procedure with sedation | 1 |
| Imaging with sedation | 1 |
| Procedure under local anaesthetic only | 0 |
Why booking, not the day
Because the useful responses take preparation. Teams may perform gastric ultrasound assessment, modify the fasting period, adjust the airway plan, or advise withholding a dose — and several of those need to be decided in advance rather than improvised in a pre-op bay.
Disclosing on the morning frequently results in a cancellation and reschedule, which is the avoidable outcome. Disclosing at booking usually results in a plan.
Say it explicitly rather than assuming it is in the record. Medication reconciliation is imperfect, and a weekly injection is easy to omit from a list oriented toward daily tablets.
| When you disclose | What typically happens | Outcome |
|---|---|---|
| At booking | Team applies its incretin protocol in advance | Procedure proceeds as planned |
| Pre-op call | Plan adjusted, sometimes fasting extended | Usually proceeds |
| Morning of procedure | Assessment or reschedule | Frequently cancelled |
| Not at all | Standard fasting assumed | Avoidable risk |
Should you skip a dose?
That decision belongs to the team managing the procedure, and it depends on the procedure type, the sedation plan, the drug, and where you are in escalation. There is no universal interval that is correct across those variables.
Do not decide independently to skip a dose before a procedure without instruction. Interrupting treatment has its own consequences — restarting after a gap can behave like a dose increase and reproduce escalation-phase side effects.
Ask the question directly when you disclose: whether to take the scheduled dose, and if not, when to resume afterwards. Getting both halves of that answer in one conversation avoids a second problem the following week.
What about afterwards?
Resumption timing is worth confirming before you leave, because post-procedure instructions tend to focus on the procedure rather than on chronic medication. If nausea or reduced intake follows a procedure, that interacts with a drug whose main effects are on appetite and gastric emptying.
Dehydration deserves particular attention in the days after any procedure involving bowel preparation or restricted intake, since volume depletion combines poorly with the reduced fluid intake that accompanies appetite suppression.
If you are having a series of procedures, ask whether the plan is the same each time or whether it changes — the answer is not always consistent across different sedation levels.
Frequently asked questions
Do I need to stop my GLP-1 before surgery?
That is a decision for your surgical and anaesthetic team. Tell them when the procedure is booked.
Why does it matter for anaesthesia?
Slowed gastric emptying can leave stomach contents present despite correct fasting, raising aspiration risk under sedation.
Does this apply to dental work?
It can, wherever sedation is used. Disclose your medication.
What about colonoscopy?
Endoscopy teams have specific protocols for incretin therapies. Tell them in advance.
When do I restart afterwards?
Confirm resumption timing with the team before you leave, along with the decision about the pre-procedure dose.
Sources
Every clinical claim above links to a primary source: an FDA record, a peer-reviewed publication with DOI or PMID, or a ClinicalTrials.gov registration. Where a figure could not be verified against a primary source, it is labelled rather than asserted.
rel="nofollow noopener". Rankings follow our
published methodology. See conflicts
of interest. This article is information, not medical advice.